NSD2 and Miyoshi myopathy: Our results on NSD2 mediated repression of HLA-DR (CD74) expression through DNA reorganisation might be clinically relevant for potential TCE escape in t(4;14) MM, but could also open potential avenues for combination therapy approaches with NSD2 inhibitors.